Citation Impact
Citing Papers
Maintenance of Human Hepatocyte Function In Vitro by Liver-Derived Extracellular Matrix Gels
2009
Cytochrome P450 2B6: function, genetics, and clinical relevance
2012
Nicotine Chemistry, Metabolism, Kinetics and Biomarkers
2009 Standout
Evaluation of mRNA expression of human drug-metabolizing enzymes and transporters in chimeric mouse with humanized liver
2005
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
Potential therapeutics for obesity and atherosclerosis: Inhibitors of neutral lipid metabolism from microorganisms
2007 StandoutNobel
Selectivity of Pyripyropene Derivatives in Inhibition toward Acyl-CoA:cholesterol Acyltransferase 2 Isozyme
2008 StandoutNobel
Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz
2005
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
(Far) Outside the box: Genomic approach to acute porphyria
2006
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Synthesis and structure–activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 3
2013 StandoutNobel
Differential Regulation of Hepatic CYP2B6 and CYP3A4 Genes by Constitutive Androstane Receptor but Not Pregnane X Receptor
2006
Oral Anticoagulant Therapy
2012 Standout
Organoid Models and Applications in Biomedical Research
2015 Standout
Porphyrias
2010 Standout
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
2008 Standout
An overview of tissue and whole organ decellularization processes
2011 Standout
An Overview of Psychotropic Drug-Drug Interactions
2005
Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation
2001
Engineering hepatocellular morphogenesis and function via ligand‐presenting hydrogels with graded mechanical compliance
2004
Synthesis and structure–activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 2
2013 StandoutNobel
Metabolism and Disposition Kinetics of Nicotine
2005
Synthesis and structure–activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 1
2013 StandoutNobel
Microfluidic organs-on-chips
2014 Standout
Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: focus on CYP3A4
2009
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells
2008 StandoutNobel
Human hepatic CYP2B6 developmental expression: The impact of age and genotype
2009
Effect of ACAT Inhibition on the Progression of Coronary Atherosclerosis
2006
Involvement of Cell Junctions in Hepatocyte Culture Functionality
2006
The Role of Human CYP2C8 and CYP2C9 Variants in Pioglitazone MetabolismIn Vitro
2009
Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy
2014 Standout
A Simple Enantioconvergent and Chemoenzymatic Synthesis of Optically Active α‐Substituted Amides
2011 StandoutNobel
Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies
2007
Capturing complex 3D tissue physiology in vitro
2006 Standout
Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins
2012
PXR and CAR: Nuclear Receptors which Play a Pivotal Role in Drug Disposition and Chemical Toxicity
2006
The Transcriptional Regulation of the Human CYP2C Genes
2009
Determination of a Degradation Constant for CYP3A4 by Direct Suppression of mRNA in a Novel Human Hepatocyte Model, HepatoPac
2015
Organotypic liver culture models: Meeting current challenges in toxicity testing
2012
A Novel Distal Enhancer Module Regulated by Pregnane X Receptor/Constitutive Androstane Receptor Is Essential for the Maximal Induction of CYP2B6 Gene Expression
2003
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
α-Tocopherol regulation of hepatic cytochrome P450s and ABC transporters in rats
2006
Relative Activation of Human Pregnane X Receptor versus Constitutive Androstane Receptor Defines Distinct Classes of CYP2B6 and CYP3A4 Inducers
2006
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
Pharmacogenetics of cyclophosphamide in patients with hematological malignancies
2005
Inhibition of Acyl‐CoA Cholesterol Acyltransferase by F12511 (Eflucimibe): Could it be a New Antiatherosclerotic Therapeutic?
2008
Liver cell lines for the study of hepatocyte functions and immunological response
2005
Further exploring r metrics for validation of QSPR models
2011 Standout
Nuclear Magnetic Resonance Metabolomic Footprinting of Human Hepatic Stem Cells and Hepatoblasts Cultured in Hyaluronan-Matrix Hydrogels
2008
Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting
2016
Advances in engineering hydrogels
2017 StandoutScience
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions
2004
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Cell and tissue engineering for liver disease
2014
Tissue Cells Feel and Respond to the Stiffness of Their Substrate
2005 StandoutScience
Pyripyropene A, an Acyl–Coenzyme A:Cholesterol Acyltransferase 2–Selective Inhibitor, Attenuates Hypercholesterolemia and Atherosclerosis in Murine Models of Hyperlipidemia
2011 StandoutNobel
Photopolymerization in 3D Printing
2019 Standout
The Many Roles for Fluorine in Medicinal Chemistry
2008 Standout
In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease
2017 StandoutNobel
Evaluating Drug Efficacy and Toxicology in Three Dimensions: Using Synthetic Extracellular Matrices in Drug Discovery
2007
Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers
2013 StandoutNobel
T‐cadherin modulates hepatocyte functions in vitro
2008
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
The Effect of Atazanavir/Ritonavir on the Pharmacokinetics of An Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate in Healthy Women
2010
Pharmacophore mapping, molecular docking and QSAR studies of structurally diverse compounds as CYP2B6 inhibitors
2010
Augmentation of Myocardial Production of 15-Epi-Lipoxin-A 4 by Pioglitazone and Atorvastatin in the Rat
2006
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
Total synthesis of pyripyropene A
2011 StandoutNobel
Impact of CYP2B6 Polymorphism on Hepatic Efavirenz Metabolismin Vitro
2007
Works of Darryl Gilbert being referenced
Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions
2001
Avasimibe Induces CYP3A4 and Multiple Drug Resistance Protein 1 Gene Expression through Activation of the Pregnane X Receptor
2003
EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO
2004
The Effect of Cyclophosphamide with and without Dexamethasone on Cytochrome P450 3A4 and 2B6 in Human Hepatocytes
2002
Comparative Effects of Thiazolidinediones on in Vitro P450 Enzyme Induction and Inhibition
2003
REGULATION OF CYP2B6 IN PRIMARY HUMAN HEPATOCYTES BY PROTOTYPICAL INDUCERS
2004
Glucocorticoid Receptor Enhancement of Pregnane X Receptor-Mediated CYP2B6 Regulation in Primary Human Hepatocytes
2003